Directors of Precision Health

Indianapolis, IN
Oct 05, 2016
Position Type

The Indiana University School of Medicine (IUSM) is pleased to announce the launch of the Precision Health Initiative, created with the bold goal of addressing major and large-scale health problems facing humanity through multidisciplinary teams of outstanding, innovative researchers. Precision Health was selected as the first recipient of funding from the Indiana University Grand Challenges Program that is a $300 million research expansion across the entire University. The $120 million investment in Precision Health will be leveraged to recruit approximately 40 new, full-time faculty members on the Indiana University campuses in Bloomington and Indianapolis. Precision Health will also support the creation of new facilities, centers, and user platforms, including new gene editing and sequencing cores at the IUSM, and a GMP facility to produce cellular therapeutics. This investment will be leveraged with other IUSM resources to significantly expand the scope of this initiative.

As part of the Precision Health Initiative, the IUSM will be recruiting visionary leaders for the below leadership positions, supported with substantial institutional resources including generous endowed chairs to support personal research and startup, funds to recruit a cadre of faculty to implement this vision, and an opportunity to leverage/expand state of the art facilities.

1.Director of Cell Therapy & Human Immunology

2.Director of Chemical Biology & Biotherapeutics

3.Director of Data Sciences & Informatics

4.Director of Genomic Medicine

Candidates interested in these leadership opportunities, or other Precision Health jobs, should visit to learn more and to apply.

The successful candidates will possess MD and/or Ph.D. degrees, extramurally funded research programs, academic credentials appropriate for an appointment with tenure, and eligibility for licensure in Indiana if applicable. It is preferred that candidates have clinical and research interests in cancer and neurological diseases in adults, children, and minority populations. The administrative expectations include strategic alignment with Precision Health goals, scientific leadership, recruiting, and fiscal responsibilities.

Indiana University is a multi-campus public research institution and a world leader in professional, medical, and technological education with an annual operating budget of $2.1 billion. The IUSM has over $320 million in grants awarded for the fiscal year 2015-2016, the majority of which come from the NIH. Additionally, IUSM provides an interdisciplinary and interactive scientific environment with many multidisciplinary centers and state-of-the-art core facilities. IUSM’s clinical partner, IU Health, operates an organized system of care across 18 hospitals that offer unmatched potential for clinical, educational, and research collaborations.